Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation. Issue 11 (2nd November 2015) - Zhou, Jinyi; Qu, Qi; Chen, Suning; Xu, Yang; Shen, Hongjie; Cen, Jiannong; Wu, Depei